LAVA Therapeutics NV

0.00 (-0.17%)
Earnings Announcements

Lava Therapeutics Posts Cash And Investments Of $110.7 Mln As Of June 30

Published: 09/13/2022 21:01 GMT
LAVA Therapeutics NV (LVTX) - Lava Therapeutics Provides Business Update and Reports Second Quarter Financial Results.
Lava Therapeutics Nv- Cash and Investments of $110.7 Million As of June 30, 2022, Providing Approximately Two Years of Cash Runway.
Lava Therapeutics NV - Qtrly Loss per Share $0.31.
Revenue is expected to be $0.33 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $0.33 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.